A novel functional DEC1 promoter polymorphism - 2249T>C reduces risk of squamous cell carcinoma of the head and neck

Carcinogenesis

Volumn 31, Issue 12, 2010, Pages 2082-2090

  Huang, Yu Jing ^a   Niu, Jiangong ^a   Wei, Sheng ^a   Yin, Ming ^a   Liu, Zhensheng ^a   Wang, Li E ^a   Sturgis, Erich M ^a   Wei, Qingyi ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TRANSCRIPTION FACTOR;

3' UNTRANSLATED REGION; ADULT; AGE; AGED; ARTICLE; BINDING SITE; CANCER RISK; CANCER STAGING; CODON; CONTROLLED STUDY; DRINKING BEHAVIOR; FEMALE; GENE ACTIVITY; GENE DELETION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HEAD AND NECK CARCINOMA; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; ONCOGENE; ONCOGENE DEC1; OROPHARYNX CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; RACE; RISK ASSESSMENT; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CODON; FEMALE; GENES, P53; HCT116 CELLS; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 78649790003     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq198     Document Type: Article

References (57)

1. Parkin,D.M. et al. (2005) Global cancer statistics, 2002. CA Cancer J. Clin., 55, 74-108.
2. Jemal,A. et al. (2010) Cancer statistics, 2010. CA Cancer J. Clin, 60, 277-300.
3. Deshpande,A.M. et al. (2008) Molecular mechanisms of head and neck cancer. Expert Rev. Anticancer Ther., 8, 799-809.
4. Ho,T. et al. (2007) Epidemiology of carcinogen metabolism genes and risk of squamous cell carcinoma of the head and neck. Head Neck, 29, 682-699.
5. Neumann,A.S. et al. (2005) Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: a review of molecular epidemiological studies. Mol. Carcinog., 42, 65-92.
6. Hu,N. et al. (2006) Genome-wide loss of heterozygosity and copy number alteration in esophageal squamous cell carcinoma using the Affymetrix GeneChip Mapping 10 K array. BMC Genomics, 7, 299.
7. Miura,K. et al. (1995) Deletion mapping in squamous cell carcinomas of the esophagus defines a region containing a tumor suppressor gene within a 4-centimorgan interval of the distal long arm of chromosome 9. Cancer Res., 55, 1828-1830.
8. Froudarakis,M.E. et al. (1998) Microsatellite instability and loss of heterozygosity at chromosomes 9 and 17 in non-small cell lung cancer. Chest, 113, 1091-1094.
9. Merlo,A. et al. (1994) Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res., 54, 640-642.
10. Takamochi,K. et al. (2001) Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung. Am. J. Pathol., 159, 1941-1948.
11. Ah-See,K.W. et al. (1994) An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res., 54, 1617-1621.
12. el-Naggar,A.K. et al. (1995) Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. Cancer Res., 55, 2656-2659.
13. Field,J.K. et al. (1995) Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival. Br. J. Cancer, 72, 1180-1188.
14. Habuchi,T. et al. (1997) A novel candidate tumour suppressor locus at 9q32-33 in bladder cancer: localization of the candidate region within a single 840 kb YAC. Hum. Mol. Genet., 6, 913-919.
15. Hirao,S. et al. (2005) Loss of heterozygosity on chromosome 9q and p.53 alterations in human bladder cancer. Cancer, 104, 1918-1923.
16. Kimura,F. et al. (2001) Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder. Br. J Cancer, 85, 1887-1893.
17. Leung,A.C. et al. (2008) Frequent decreased expression of candidate tumor suppressor gene, DEC1, and its anchorage-independent growth properties and impact on global gene expression in esophageal carcinoma. Int. J. Cancer, 122, 587-594.
18. Nishiwaki,T. et al. (2000) Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32. Genes Chromosomes Cancer, 27, 169-176.
19. Yang,L. et al. (2005) Tumor suppressive role of a 2.4 Mb 9q33-q34 critical region and DEC1 in esophageal squamous cell carcinoma. Oncogene, 24, 697-705.
20. 20.Canova,C. et al. (2009) Genetic associations of 115 polymorphisms with cancers of the upper aerodigestive tract across 10 European countries: the ARCAGE project. Cancer Res., 69, 2956-2965.
21. Hancox,R.J. et al. (2009) Accelerated decline in lung function in cigarette smokers is associated with TP53/MDM2 polymorphisms. Hum. Genet., 126, 559-565.
22. Li,Y. et al. (2009) A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: evidence from 15,857 subjects. Lung Cancer, 66, 15-21.
23. Zemleduch,T. et al. (2009) Contribution of polymorphism in codon 72 of TP53 gene to laryngeal cancer in Polish patients. Oral Oncol., 45, 683-686.
24. Niu,J. et al. (2009) Genetic polymorphisms in the PTPN13 gene and risk of squamous cell carcinoma of head and neck. Carcinogenesis, 30, 2053-2058.
25. Wang,L.E. et al. (2010) Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics. Clin. Cancer Res., 16, 764-774.
26. Andrews,N.C. et al. (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res., 19, 2499.
27. Lee,Y. et al. (1998) The cardiac tissue-restricted homeobox protein Csx/Nkx2.5 physically associates with the zinc finger protein GATA4 and cooperatively activates atrial natriuretic factor gene expression. Mol. Cell. Biol., 18, 3120-3129.
28. Shiojima,I. et al. (1999) Context-dependent transcriptional cooperation mediated by cardiac transcription factors Csx/Nkx-2.5 and GATA-4. J. Biol. Chem., 274, 8231-8239.
29. Stephens,M. et al. (2005) Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am. J. Hum. Genet., 76, 449-462.
30. Stephens,M. et al. (2001) A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet., 68, 978-989.
31. Srivastava,K. et al. (2010) Polymorphisms in ERCC2, MSH2, and OGG1 DNA repair genes and gallbladder cancer risk in a population of Northern India. Cancer, 116, 3160-3169.
32. Steinberg,D. et al. (1997) CART: Tree-Structured Non-Parametric Data Analysis. Salford Systems, San Diego, CA.
33. Zhang,H. et al. (2000) Use of classification trees for association studies. Genet. Epidemiol., 19, 323-332.
34. Chen,K. et al. (2008) Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis, 29, 1306-1311.
35. Yu,Z. et al. (2007) Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res., 35, 4535-4541.
36. Cortezzi,S.S. et al. (2004) Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas. Cancer Genet. Cytogenet., 150, 44-49.
37. Drummond,S.N. et al. (2002) TP53 codon 72 polymorphism in oral squamous cell carcinoma. Anticancer Res., 22, 3379-3381.
38. Katiyar,S. et al. (2003) Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. Mol. Cell. Biochem., 252, 117-124.
39. Lu,J. et al. (2007) 172>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant. Carcinogenesis, 28, 988-994.
40. Shen,H. et al. (2002) P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett., 183, 123-130.
41. Sousa,H. et al. (2006) Linkage of TP53 codon 72 pro/pro genotype as predictive factor for nasopharyngeal carcinoma development. Eur. J. Cancer Prev., 15, 362-366.
42. Summersgill,K.F. et al. (2000) p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 90, 334-339.
43. Tiwawech,D. et al. (2003) The p53 codon 72 polymorphism in Thai nasopharyngeal carcinoma. Cancer Lett., 198, 69-75.
44. Twu,C.W. et al. (2006) Association of p53 codon 72 polymorphism with risk of hypopharyngeal squamous cell carcinoma in Taiwan. J. Formos. Med. Assoc., 105, 99-104.
45. Komuro,I. et al. (1993) Csx: a murine homeobox-containing gene specifically expressed in the developing heart. Proc. Natl Acad. Sci. USA, 90, 8145-8149.
46. Lints,T.J. et al. (1993) Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development, 119, 419-431.
47. Apergis,G.A. et al. (1998) A novel nk-2-related transcription factor associated with human fetal liver and hepatocellular carcinoma. J. Biol. Chem., 273, 2917-2925.
48. Kajiyama,Y. et al. (2002) Regulation of alpha-fetoprotein expression by Nkx2.8. Mol. Cell. Biol., 22, 6122-6130.
49. Dentice,M. et al. (2004) Transcription factor Nkx-2.5 induces sodium/iodide symporter gene expression and participates in retinoic acid- and lactationinduced transcription in mammary cells. Mol. Cell. Biol., 24, 7863-7877.
50. Kwabi-Addo,B. et al. (2007) Age-related DNA methylation changes in normal human prostate tissues. Clin. Cancer Res., 13, 3796-3802.
51. Shibata,K. et al. (2008) Establishment and characterization of an ovarian yolk sac tumor cell line reveals possible involvement of Nkx2.5 in tumor development. Oncology, 74, 104-111.
52. Chen,C.Y. et al. (1996) Activation of the cardiac alpha-actin promoter depends upon serum response factor, Tinman homologue, Nkx-2.5, and intact serum response elements. Dev. Genet., 19, 119-130.
53. Chen,C.Y. et al. (1996) Recruitment of the tinman homolog Nkx-2.5 by serum response factor activates cardiac alpha-actin gene transcription. Mol. Cell. Biol., 16, 6372-6384.
54. Dentice,M. et al. (2003) The different cardiac expression of the type 2 iodothyronine deiodinase gene between human and rat is related to the differential response of the Dio2 genes to Nkx-2.5 and GATA-4 transcription factors. Mol. Endocrinol., 17, 1508-1521.
55. Sepulveda,J.L. et al. (1998) GATA-4 and Nkx-2.5 coactivate Nkx-2 DNA binding targets: role for regulating early cardiac gene expression. Mol. Cell. Biol., 18, 3405-3415.
56. Small,E.M. et al. (2003) Transgenic analysis of the atrialnatriuretic factor (ANF) promoter: kx2-5 and GATA-4 binding sites are required for atrial specific expression of ANF. Dev. Biol., 261, 116-131.
57. Bimber,B. et al. (2007) Differential regulation of Tbx5 protein expression and sub-cellular localization during heart development. Dev. Biol., 302, 230-242.